Sur vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Sur
82.0%
in 2024
Tajikistan
100.0%
in 2024
Sur rank
2nd
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sur
- Tajikistan
How they compare
Tajikistan currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Tajikistan's figure about 1.2 times Sur's.
The two have swapped places 4 times across 16 shared years of data; in 2008 it was Tajikistan ahead.
Sur ranks 2nd and Tajikistan ranks 1st of 2 regions.
Across the 3 decades both report, Sur averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Sur | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.0% | 40.0% | 1.0% | Sur |
| 2010s | 66.8% | 74.2% | 7.4% | Tajikistan |
| 2020s | 75.8% | 97.8% | 22.0% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sur or Tajikistan?
- Tajikistan, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sur and Tajikistan?
- 18.0%, with Tajikistan ahead.
- How many years of comparable data are there for Sur and Tajikistan?
- 16 years are reported by both, from 2008 to 2024.
- How do Sur and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd and Tajikistan ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.